{"version":"1.0","type":"link","title":"Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.","author_name":"Park JC 외","author_url":"https://prs-insight.online/author/Park%20JC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97627","thumbnail_width":1200,"thumbnail_height":630}